Zelira Therapeutics Ltd. announced the launch of a new product ITURA - Advanced Relief Cream Formula through its partnership with Cardiovascular Solutions of Central Mississippi (CVSCM). ITURA is an advanced relief cream formula using CBD and Hemp Spectra Technology that targets multi-symptoms such as numbness and tingling, muscle cramps, insensitivities and neuropathies including pain associated with Peripheral Artery Disease and diabetes.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.71 AUD | +1.43% | 0.00% | -21.11% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-21.11% | 5.15M | |
-0.15% | 105B | |
+3.86% | 97.5B | |
+2.71% | 22.19B | |
-16.09% | 21.33B | |
-7.35% | 18.68B | |
-41.41% | 16.6B | |
-19.83% | 14.52B | |
+8.12% | 14.09B | |
+22.20% | 10.99B |
- Stock Market
- Equities
- ZLD Stock
- News Zelira Therapeutics Limited
- Zelira Therapeutics Limited Successfully Launches ITURA with CVSCM